Randox Appoint US Director as Part of Strategic Expansion in the States

Home - Randox Appoint US Director as Part of Strategic Expansion in the States
statue-of-liberty

This appointment is of strategic importance in Randox’s plans to increase its market presence in the United States. As part of this Randox is committed to increasing its on the ground leadership and customer support network, with a view to significantly expanding its US market share.

Schaefering brings a wealth of experience to Randox from a career spanning more than 20 years in the industry. He joins Randox from Bio-Rad where he was National Account Manager handling the negotiation and contract management for several GPOs and key accounts including Quest Diagnostics, MedAssets and Premier.

Moving to Randox, Schaefering said:

In today’s healthcare climate, labs are increasing looking for opportunities: opportunities to increase productivity; to be more efficient; to realize labor savings, but without sacrificing on quality. Randox brings opportunity and quality that has largely been missing in the US until now. With QC solutions that are increasingly regarded as the highest quality and most accurate available globally, Randox stands apart from the competition.

Randox Chief Customer Officer, David Brown said:

“Offering first-class customer support is one of the fundamental tenets on which Randox operates. As we grow our customer base in the US we are committed to also growing our customer support network. John Schaefering’s appointment is a key step to ensure our US customers have access to on the ground assistance as and when they need it.”

Randox has had the US market in its sights since 2010, when it opened its 33,000ft² US Headquarters in West Virginia following a multimillion dollar investment. The company’s determination to grow its US market share was reasserted earlier this year when it announced plans to expand its West Virginia HQ into a key manufacturing facility, significantly expanding the company’s capabilities Stateside.

Randox recently announced that it’s won a major supplier agreement with leading healthcare supply chain company Novation, meaning its third party quality control products will now be readily available to hospital organizations throughout the US.

statue-of-liberty

Request a meeting
×
Make an Enquiry - RX series
×
Make an Enquiry - Reagents
  • This field is for validation purposes and should be left unchanged.
×
Kit Insert Request - Reagents
×
Kit Insert Request - Reagents
×
Make an Enquiry - Reagents
×
Make an Enquiry - Quality Control
×
Make an Enquiry - RIQAS
×
Make an Enquiry - RIQAS
×
Make an Enquiry - Quality Control
×
Make an Enquiry
×
Make an Enquiry - Biochip
  • This field is for validation purposes and should be left unchanged.
×
Make an Enquiry - Molecular
  • This field is for validation purposes and should be left unchanged.
×
Make an Enquiry - Future Diagnostics
×
Make an Enquiry - RX series (Product)
×
Make an Enquiry - Quality Control
×
Make an Enquiry - RIQAS
×
Make an Enquiry - Reagents
×
Por favor, introduzca sus datos para ver nuestro último seminario
×